MGI Tech’s DNBSEQ-E25 and G99 platforms set record for sequencing applications at high altitude

FHS
June 7, 2024
8:59 am

MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, recently set a new record for sequencing applications by successfully running sample testing on its cutting-edge DNBSEQ-E25 and DNBSEQ-G99 platforms on Mount Everest.

Study suggests NSAIDs may lower postoperative delirium risk

Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, may help reduce patients’ risk of postoperative delirium, according to a study presented at the ANESTHESIOLOGY® 2024 annual

October 21, 2024

Startup Neumora takes a novel depression drug to Phase 3

Neumora, a privately held biotech company, is moving into the final phase of testing with a novel treatment for depression that showed promise in a

July 18, 2023

Where are HHS and the FTC on online privacy for people with substance use disorder?

The era of rampant, unconsented, and unregulated online data collection may finally be winding down for consumer health data. But the advances in consumer privacy

September 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.